Sort
17,828 grants matching “crispr”
Identification of a New RIPK3-Dependent Cell Death Pathway
$78,750Pranav Danthi · Trustees Of Indiana University · R03 · FY2019 · AI
Identification of regulatory elements in the Il9 gene
$78,750Mark H. Kaplan · Indiana University Indianapolis · R03 · FY2019 · AI
Killing dormant tumor cells: the role of autopagy
$78,750Amanda Simcox · Ohio State University · R03 · FY2023 · CA
Generation of an ILC3-specific Cre driver in mice
$78,750Eugene M. Oltz · Ohio State University · R03 · FY2024 · AI
Regulation of membrane trafficking by Coronins
$78,627Silvia Jansen · Washington University · R01 · FY2024 · GM
Deciphering the mechanism of SHIP1 regulation in human neutrophils
$78,598Scott David Hansen · University Of Oregon · R01 · FY2022 · GM
Nanoparticle Coated Microelectrode Arrays for Electrochemically Controlled Gene Editing at the Electrode Site
$78,580Nathaniel P Williams · University Of Pittsburgh At Pittsburgh · F32 · FY2023 · MH
The Importance of the Batf3/Irf4 Pathway in Growth Hormone and Inflammation Mediated Metabolic Changes in Adipose Tissue
$78,558Armen I Yerevanian · Massachusetts General Hospital · F32 · FY2020 · DK
Targeting MCL-1 dependent apoptotic vulnerability of KRAS-LKB1 NSCLC
$78,550Chendi Li · Massachusetts General Hospital · F32 · FY2022 · CA
Characterizing the effects of cis-regulatory variation on patient outcomes and treatment response in Multiple Myeloma
$78,548Linh T Bui-Raborn · Translational Genomics Research Inst · F32 · FY2022 · CA
Investigating the role of dorsal raphe nucleus enkephalin neurons in motivational and affective behaviors during chronic pain
$78,520Kathryn I Braden · Washington University · F32 · FY2025 · DA
Astrocyte dynamics in spinal cord injury and their impact on regeneration
$78,520Alexandria Lassetter Hulegaard · University Of Pennsylvania · F32 · FY2025 · HD
The Role of E2F2 in HER2 Positive Breast Cancer
$78,516Jonathan Rennhack · Dana-Farber Cancer Inst · K00 · FY2018 · CA
Developing humanized Nut Carcinoma mouse model for developing NUTM1 targeted therapies.
$78,500Bin Gu · Henry Ford Health + Michigan State University Health Sciences · R03 · FY2024 · CA
Developing humanized Nut Carcinoma mouse model for developing NUTM1 targeted therapies.
$78,500Bin Gu · Henry Ford Health + Michigan State University Health Sciences · R03 · FY2025 · CA
Deciphering unintended large gene modifications in gene editing for sickle cell disease
$78,410Gang Bao · Rice University · R01 · FY2024 · HL
Cas9 RNP targeting cis-regulatory elements in lymphocytes
$78,366Karl Mark Ansel · University Of California, San Francisco · R01 · FY2022 · HL
Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes
$78,276Julia Tcw · Boston University Medical Campus · R01 · FY2024 · AG
CRISPRi-Tn-Seq: A genome-wide high throughput tool for bacterial essential and nonessential genetic-interaction mapping.
$78,250Tim Van Opijnen · Boston College · R03 · FY2019 · AI
CRISPRi-Tn-Seq: A genome-wide high throughput tool for bacterial essential and nonessential genetic-interaction mapping.
$78,250Tim Van Opijnen · Boston College · R03 · FY2018 · AI
Directed Clonal Evolution of Drug Resistant BRAF Mutant Melanoma for Cross-Sensitization to MAPK Hyperactivation
$78,040Eunice Cho · Broad Institute, Inc. · F32 · FY2025 · CA
Elucidating the role of PATZ1 in MYCN-amplified neuroblastoma
$78,040Melinda Soeung · Dana-Farber Cancer Inst · F32 · FY2025 · CA
Discovery of the mechanisms of resistance for the anthelmintic emodepside
$78,040Amanda Shaver · Johns Hopkins University · F32 · FY2025 · AI
CXCL13 as an aging-associated defect in memory T cell homeostasis
$78,040Casey Beppler · Stanford University · F32 · FY2025 · AI
What is the mechanism by which a gene essential for Rhabdoid tumor viability regulates Chromatin function?
$78,040Jordan A. Cockfield · St. Jude Children'S Research Hospital · F32 · FY2025 · CA